Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$228.26 - $319.04 $1.78 Million - $2.49 Million
7,799 Added 18.96%
48,928 $15.6 Million
Q1 2024

May 03, 2024

BUY
$210.76 - $249.51 $123,505 - $146,212
586 Added 1.45%
41,129 $9.45 Million
Q4 2023

Feb 08, 2024

BUY
$214.88 - $256.94 $146,977 - $175,746
684 Added 1.72%
40,543 $8.92 Million
Q3 2023

Nov 09, 2023

SELL
$211.82 - $248.24 $294,217 - $344,805
-1,389 Reduced 3.37%
39,859 $9 Million
Q2 2023

Aug 07, 2023

BUY
$205.19 - $232.99 $76,741 - $87,138
374 Added 0.92%
41,248 $9.11 Million
Q1 2023

May 01, 2023

BUY
$212.99 - $276.17 $2.18 Million - $2.83 Million
10,233 Added 33.4%
40,874 $9.15 Million
Q4 2022

Feb 07, 2023

SELL
$205.95 - $280.43 $431,671 - $587,781
-2,096 Reduced 6.4%
30,641 $8.52 Million
Q3 2022

Oct 25, 2022

SELL
$203.3 - $244.17 $1,016 - $1,220
-5 Reduced 0.02%
32,737 $6.85 Million
Q2 2022

Aug 08, 2022

BUY
$174.81 - $241.14 $142,120 - $196,046
813 Added 2.55%
32,742 $7.72 Million
Q1 2022

May 06, 2022

SELL
$166.16 - $213.96 $89,726 - $115,538
-540 Reduced 1.66%
31,929 $5.73 Million
Q4 2021

Feb 08, 2022

SELL
$184.32 - $216.08 $136,212 - $159,683
-739 Reduced 2.23%
32,469 $7.02 Million
Q3 2021

Oct 28, 2021

SELL
$179.86 - $214.88 $31,475 - $37,604
-175 Reduced 0.52%
33,208 $6.13 Million
Q2 2021

Jul 27, 2021

BUY
$170.47 - $211.93 $17,728 - $22,040
104 Added 0.31%
33,383 $5.99 Million
Q1 2021

May 03, 2021

SELL
$153.94 - $174.85 $370,225 - $420,514
-2,405 Reduced 6.74%
33,279 $5.57 Million
Q4 2020

Feb 04, 2021

SELL
$101.87 - $151.79 $591,559 - $881,444
-5,807 Reduced 14.0%
35,684 $5.42 Million
Q3 2020

Nov 06, 2020

BUY
$99.9 - $121.13 $671,128 - $813,751
6,718 Added 19.32%
41,491 $4.19 Million
Q2 2020

Aug 04, 2020

SELL
$92.74 - $125.82 $233,333 - $316,563
-2,516 Reduced 6.75%
34,773 $4.21 Million
Q1 2020

Apr 27, 2020

BUY
$79.39 - $115.35 $577,482 - $839,055
7,274 Added 24.23%
37,289 $3.54 Million
Q4 2019

Feb 03, 2020

BUY
$78.31 - $95.34 $13,234 - $16,112
169 Added 0.57%
30,015 $2.64 Million
Q3 2019

Oct 31, 2019

BUY
$74.85 - $85.99 $8,458 - $9,716
113 Added 0.38%
29,846 $2.38 Million
Q2 2019

Aug 09, 2019

BUY
$76.06 - $120.81 $3,498 - $5,557
46 Added 0.15%
29,733 $2.32 Million
Q1 2019

May 02, 2019

BUY
$107.15 - $126.84 $124,722 - $147,641
1,164 Added 4.08%
29,687 $3.48 Million
Q4 2018

Feb 11, 2019

BUY
$101.4 - $128.73 $112,858 - $143,276
1,113 Added 4.06%
28,523 $3.11 Million
Q3 2018

Oct 22, 2018

SELL
$113.81 - $129.46 $78,984 - $89,845
-694 Reduced 2.47%
27,410 $3.51 Million
Q2 2018

Jul 23, 2018

SELL
$101.14 - $118.31 $52,795 - $61,757
-522 Reduced 1.82%
28,104 $3.18 Million
Q1 2018

Apr 20, 2018

SELL
$107.21 - $151.94 $62,610 - $88,732
-584 Reduced 2.0%
28,626 $3.22 Million
Q4 2017

Jan 23, 2018

SELL
$118.58 - $151.28 $297,042 - $378,956
-2,505 Reduced 7.9%
29,210 $4.32 Million
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $3.63 Million - $4.34 Million
31,715
31,715 $3.72 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.